Silent nephritis in systemic lupus erythematosus

Lupus

Volumn 12, Issue 1, 2003, Pages 26-30

  Zabaleta Lanz, M ^a,c   Vargas Arenas, R E ^a   Tapanes F ^a   Daboin, I ^b   Atahualpa Pinto, J ^b   Bianco, N E ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c Instituto de Inmunologa   (United States)

Author keywords

Lupus nephritis; Overt lupus nephropathy; Silent lupus nephritis; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DNA ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GLOMERULOPATHY; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNE MEDIATED INJURY; IMMUNOPATHOLOGY; KIDNEY BIOPSY; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; SEX RATIO; SYSTEMIC LUPUS ERYTHEMATOSUS; URINE SEDIMENT;

ADOLESCENT; ADULT; AGED; BIOPSY; CHILD; CREATININE; FEMALE; HUMANS; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NECROSIS; PREVALENCE; PROTEINURIA;

EID: 0347298722     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu259oa     Document Type: Article

References (35)

1. Lee SH, Mujais SK, Kasinath BS et al. Course of renal pathology in patients with Systemic Lupus Erythematosus. Am J Med 1984; 77: 612-620.
2. Balow JE, Boumpas DT, Austin HA III. Renal disease. In: Schur PH (ed.). The Clinical Management of Systemic lupus erythematosus. Lippicontt-Raven: Philadelphia, PA, 1996, pp 109-126.
3. Kotzin BL, West SG. Systemic lupus erythematosus. In: Clinical Immunology: Principles and Practice. Mosby: London, 2001, 1-24.
4. Ahmadian YS, Given GZ, Mendoza SA. Normal urine and positive immunofluorescence reaction in lupus nephritis. Am J Dis Child 1972; 123: 121-125.
5. Mahajan SK, Ordoñez NG, Freitelson PJ et al. Lupus nephropathy without clinical renal involvement. Medicine (Balt) 1977; 56: 493-501.
6. D'Agati VD. Renal disease in systemic lupus erythematosus, mixed connective tissue disease, Sjögren's syndrome, and rheumatoid arthritis. In: Jennette JCh, Olson JL, Schwartz MM, Silva FG (eds). Heptinstall's Pathology of the Kidney. Lippincott-Raven: Philadelphia, PA, 1998, pp 541-624.
7. Perez-Rojas G, Suarez-Chacón R, Penchaszadeh G et al. Pathophysiology of the immune response in systemic lupus erythematosus: a new approach. In: Zabrieskie J (ed.). Proceedings of Streptococcal Diseases and Immune Response. Academic Press, New York, 1980, pp 507-519.
8. Appel GB, Silva FG, Pirani CI et al. Renal involvement in systemic lupus erythematosus (SLE): a study of 56 patients emphasizing histologic classification. Medicine (Balt) 1978; 57: 371-410.
9. Ginzler EM, Nicastri AD, Chen CK et al. Progression of mesangial and focal to diffuse lupus nephritis. New Engl J Med 1974; 291: 693-696.
10. Mahajan SK, Ordoñez NG, Spargo BH et al. Changing histopathology patterns in lupus nephropathy. Clin Nefrol 1978; 10: 1-8.
11. Morel-Maroger L, Méry JP, Droz D et al. The course of lupus nephritis: contribution of serial renal biopsies. In: Hamburger J, Crosnier J, Maxwell MH (eds). Advances in Nephrology. Year Book Medical: Chicago, IL, 1976, pp 79-118.
12. Lentz RD, Michael AF, Friend PS. Membranous transformation of lupus nephritis. Clin Immunol Immunopathol 1981; 19: 131-136.
13. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25 (11): 1271-1277.
14. Bombardier C, Gladman DD, Urowitz MB and the Committee on prognosis studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992; 35 (6): 630-640.
15. Ter Borg EJ, Horst G, Hummel EJ et al. Measurement of increases in anti-double stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus; a long-term prospective study. Arthritis Rheum 1990; 33: 634-643.
16. Towbin H, Sthaelin T, Gordon J. Electrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4354.
17. Mc Duffie FC, Byrd MG, Dougal JS et al. Immunodiffusion assay for detection of antibodies to Sm, U1-RNP, SSA/Ro, SSB/La, SC1-70 and Jo 1. In: Cavallaro JJ, Mc Duffle FC, Byrd MG, Mc Dougal JS (eds). Laboratory Methods for Detection of Antinuclear Antibodies. Atlanta, GA: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, 1987, pp 105-136.
18. Orozco A, Sánchez P, Bianco NE et al. Solid phase C1q microassay for the rapid detection of circulating immunocomplexes. J Immunol Meth 1983; 59: 237-243.
19. Kent JF, Fife EH. Precise standardization of reagents in complement assays. Am J Trop Med Hyg 1963; 12: 103-106.
20. Schwartz MM. The pathologic diagnosis of renal disease. In: Jennette JCh, Olson JL, Schwartz MM, Silva FG (eds). Heptinstall's Pathology of the Kidney. Lippincott-Raven: New York, 1998, pp 169-180.
21. Churg J, Bernstein J, Glassock RJ. Renal Disease: Classification and Atlas of Glomerular Diseases: Lupus Nephritis. Igaku-Shoin: New York, 1995, pp 151-156.
22. Ingelfinger JA, Mosteller F, Thibodeau LA, Ware JH. Biostatistics in Clinical Medicine. Mc Graw Hill: New York, 1994, p 418.
23. McLaughlin JR, Gladman DD, Urowitz MB et al. Kidney biopsy in systemic lupus erythematosus. II. Survival analysis according to biopsy results. Arthritis Rheum 1991; 34: 1268-1273.
24. Cameron JS. Disease of the month: lupus nephritis. J Am Soc Nephrol 1999; 10: 413-424.
25. Pollak VE, Pirani CL. Lupus Nephritis. Pathology, pathogenesis, clinicopathologic correlation and prognosis. In: Wallace DJ, Hannahs Hahn B (eds). Dubois' Lupus Erythematosus. Lea & Febiger: Philadelphia, PA, 1993, pp 525-541.
26. Hermann M, Winller T, Gaipl U et al. Etiopathogenesis of systemic lupus erythematosus. Int Arch Allergy Immunol 2000; 123: 28-35.
27. Mohan C, Datta SK. Short analytical review. Lupus: key pathogenic mechanism and contributing factors. Clin Immunol Immunopathol 1995; 77 (3): 209-220.
28. Arbuckle MR, James JA, Kohlhase KF et al. Development of anti-ds DNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand J Immunol 2001; 54: 211-219.
29. Tápanes FJ, Vásquez M, Ramirez R et al. Cluster analysis of antinuclear autoantibodies in the prognosis of SLE nephropathy: are anti-extractable antinuclear antibodies protective? Lupus 2000; 9: 437-444.
30. Huong TDL, Papo T, Beaufils H et al. Renal involvement in Systemic Lupus Erythematosus: a study of 180 patients from a single center. Medicine 1999; 78: 148-166.
31. Falk RJ. Editorial: Treatment of lupus nephritis. A work in progress. New Engl J Med 2000; 343 (16): 1182-1183.
32. Austin HA III, Boumpas DT, Vaughn EM et al. Predicting renal outcomes in severe lupus nephritis. Contributions of clinical and histologic data. Kidney Int 1994; 45: 544-550.
33. Donadio JV jr, Hart GM, Bergstralh EJ et al. Prognostic determinants in lupus nephritis. A long-term clinic-pathologic study. Lupus 1995; 4: 109-115.
34. Nossent H, Berden J, Swaak T. Renal immunofluorescence and the prediction of renal outcome in patients with proliferative lupus nephritis. Lupus 2000; 9 (7): 504-510.
35. Gonzalez-Crespo MR, López-Fernández JL, Usera G et al. Outcome of silent nephritis. Sem Arthritis Rheum 1996; 26: 468-476.